Last update:
Oncology & Cancer news
Oncology & Cancer
Cancer's hidden 'safety switch': Silencing TAK1 gene could boost immunotherapy performance
Australian researchers have discovered that the TAK1 gene helps cancer cells survive attack from the immune system, revealing a mechanism that may limit the effectiveness of immunotherapy treatments.
1 hour ago
0
0
Oncology & Cancer
Comprehensive study settles debate over diet safety for patients with cancer
For decades, patients undergoing blood cancer treatment have been told to avoid certain foods to reduce infection risk, guidance that some physicians hoped could safely be relaxed. Now, a University of Florida study offers ...
5 hours ago
0
0
For Black women with breast cancer, ultra-processed foods may worsen health outcomes
A study by Rutgers Cancer Institute researchers is the first to link ultra-processed foods to reduced survival in Black women with breast cancer.
20 hours ago
0
0
Latin American research indicates a lower prevalence of a type of head and neck cancer
Squamous cell carcinoma is one of the most common and aggressive types of cancer in the head and neck region. It is the fifth-most common cancer and the sixth-leading cause of cancer death. Accounting for about 95% of cancer ...
20 hours ago
0
0
Promising target improves antitumor response in preclinical models of pancreatic cancer
Researchers at The University of Texas MD Anderson Cancer Center have found that a mitochondrial enzyme, GFER, creates an immunosuppressive environment within pancreatic tumors, leading to treatment resistance.
23 hours ago
0
0
New Raman imaging system detects subtle tumor signals
Researchers have developed a new compact Raman imaging system that is sensitive enough to differentiate between tumor and normal tissue. The system offers a promising route to earlier cancer detection and to making molecular ...
Dec 18, 2025
0
0
AI can help detect kidney cancer faster
Researchers have developed an AI-based tool that accelerates the detection of kidney cancer. Its effectiveness was validated in a study published in Communications Medicine.
Dec 18, 2025
0
0
Living longer with tailored chemotherapy—despite incurable cancer
Just a few months ago, Ragnhild Vigdis Langli (70) was planning her own funeral.
Dec 18, 2025
0
0
Subtyping colorectal cancer may improve patient outcome predictions
Colorectal cancer, or CRC, is the world's second most lethal cancer based on the number of deaths, and is the third most prevalent malignant tumor. Doctors and patients have long been hoping for better diagnostics for prognosis, ...
Dec 18, 2025
0
0
Thick melanoma tumors may be linked to poorer survival than some metastatic cases
The current melanoma staging system does not always reflect actual survival outcomes. In some cases, patients with thick but localized tumors have poorer long-term survival than those with melanoma that has spread to nearby ...
Dec 18, 2025
0
0
WISDOM trial weighs risk-based cancer screening
University of California, San Francisco investigators led WISDOM, a randomized comparison of risk-based breast cancer screening and annual mammography. Rates of stage ≥IIB breast cancers met a noninferiority threshold under ...
Engineered dendritic cells boost cancer immunotherapy
EPFL researchers have successfully engineered cells of the immune system to more effectively recognize cancer cells. The work, covered in two papers, turns the previously lab-based method into a full-blown immunotherapy strategy.
Dec 17, 2025
0
8
RNA-based molecule enhances therapies against pancreatic cancer
A research group at the Italian Institute of Technology (IIT-Istituto Italiano di Tecnologia) has identified a candidate molecule that could improve current therapies against pancreatic cancer. The team designed the new molecule, ...
Dec 17, 2025
0
0
'Molecular glue' stabilizes protein that inhibits development of non-small cell lung cancer
Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80% of lung cancers are non-small cell lung cancers, in which tumor cells are larger and grow more slowly than ...
Dec 17, 2025
0
0
Link between tumor metabolism and drug efficacy in cancer cells may help advance precision chemotherapy
Chemotherapy drugs that target cancer cells without damaging normal cells remain one of the key goals of precision medicine in cancer treatment. The challenge is designing drugs that do this effectively.
Dec 17, 2025
0
0
New risk score helps predict pancreatic cancer recurrence
Cedars-Sinai investigators, leading a multi-institutional team, have developed and validated a tool to predict which patients with pancreatic neuroendocrine tumors (PanNETs) need closer monitoring because their cancer is ...
Dec 17, 2025
0
0
Ultrasensitive liquid biopsy affective in predicting and monitoring immunotherapy response, study shows
Published today in Clinical Cancer Research, findings from a study led by investigators at the Vall d'Hebron Institute of Oncology (VHIO), which forms part of the Vall d'Hebron Campus, underscore the efficacy of analyzing ...
Dec 17, 2025
0
0
How to reduce risk of lymphedema after head and neck cancer
Lymphedema after head and neck cancer is considerably more common than previously assumed and can persist long after cancer treatment has finished. Researchers at Lund University in Sweden have discovered that patients with ...
Dec 17, 2025
0
1
Giving less chemotherapy can still cure lymphoma patients in their 80s, study says
People aged 80 and older with a common type of lymphoma can take a half-dose of chemotherapy and be cured or significantly extend their survivorship with fewer toxic side effects, a new study shows.
Dec 17, 2025
0
0
Black patients diagnosed with aggressive leukemia experience worse outcomes
Compared with white patients, Black patients with an aggressive form of leukemia—called acute myeloid leukemia (AML)—were on average more than five years younger at diagnosis and more than 30% more likely to die of their ...
Dec 17, 2025
0
0
New technology reduces false positives in breast ultrasounds
New ultrasound technology developed at Johns Hopkins can distinguish fluid from solid breast masses with near perfect accuracy, an advance that could save patients, especially those with dense breast tissue, from unnecessary ...
Dec 17, 2025
0
0
Alcohol-linked DNA damage tied to cancer risk: Study reveals repair enzyme's role
Alcohol consumption leads to the formation of a toxic compound called acetaldehyde, which damages DNA. A research team from IOCB Prague has now described in detail how cells repair this damaged genetic information.
Dec 16, 2025
0
17
Ultrasound paired with vibrating nanoparticles softens tumor tissue, improving drug delivery
Cancer is one of the leading causes of death in the U.S., second only to heart disease. But a new cancer treatment method from CU Boulder researchers uses sound waves to soften tumors and could be a potent tool against the ...
Dec 16, 2025
0
2
New understanding of T cell receptors may improve cancer immunotherapies
One of the most exciting advances in cancer treatments in the past decade is the development of T cell immunotherapies, in which a patient's own immune system is trained to recognize and attack dangerous cells. Yet a full ...
Dec 16, 2025
0
18
Colorectal cancer's immune puzzle cracked: Two Treg cell types shape survival odds
In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the immune system's ability to fight against a tumor.
Dec 16, 2025
0
0
